Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.
about
Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@en
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@nl
type
label
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@en
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@nl
prefLabel
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@en
Longitudinal serum metabolomic ...... sitive breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Longitudinal serum metabolomic ...... ositive breast cancer patients
@en
P2093
Arnaud M Vigneron
Céline Mahier Aït-Oukhatar
Elodie Jobard
Jacques Bonneterre
Jean-Louis Merlin
Maria Rios
Mario Campone
Marta Jimenez
Monica Arnedos
Thomas Bachelot
P2860
P304
83570-83584
P356
10.18632/ONCOTARGET.18784
P407
P577
2017-06-28T00:00:00Z